Nykode Therapeutics AS

OB:NYKD Stock Report

Market Cap: NOK 713.8m

Nykode Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OB:NYKD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Oct 25BuyNOK 100,140Michael EngsigIndividual55,944NOK 1.79
10 Oct 25BuyNOK 316,771Capital Research and Management CompanyCompany150,114NOK 2.11
27 Mar 25BuyNOK 6,416,396Norda ASACompany3,000,000NOK 2.14
20 Dec 24BuyNOK 300,000Caaby ASCompany100,000NOK 3.00
20 Dec 24SellNOK 300,000Christian ÅbyholmIndividual100,000NOK 3.00

Insider Trading Volume

Insider Buying: NYKD insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NYKD?
Owner TypeNumber of SharesOwnership Percentage
Public Companies15,996,7554.9%
VC/PE Firms26,000,0007.96%
Individual Insiders49,194,07515.1%
General Public49,767,75515.2%
Private Companies75,786,95323.2%
Institutions109,800,90633.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 81.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
Jan Haudemann-Andersen
41,189,050NOK 90.0m0%no data
10%
Capital Research and Management Company
32,774,030NOK 71.6m105%no data
9.24%
Rasmussengruppen AS
30,180,750NOK 66.0m0%13.88%
7.96%
Datum Opportunity As
26,000,000NOK 56.8m0%no data
5.42%
Victoria India Fund AS
17,705,175NOK 38.7m0%no data
4.9%
Norda ASA
15,996,755NOK 35.0m0%no data
4.61%
State Street Global Advisors, Inc.
15,059,133NOK 32.9m0%no data
3.85%
Datum Invest AS
12,560,250NOK 27.5m0%no data
3.23%
Joh Johannson Eiendom AS
10,561,631NOK 23.1m0%no data
3.16%
RADFORSK
10,315,311NOK 22.5m0%50.43%
2%
Om Holding AS
6,519,525NOK 14.3m0%no data
1.72%
Handelsbanken Asset Management
5,603,165NOK 12.2m0%no data
1.52%
Simen Thorsen
4,950,000NOK 10.8m0%no data
1.38%
Portia AS
4,500,000NOK 9.8m0%no data
1.37%
Krag Invest As
4,470,100NOK 9.8m0%no data
1.03%
AS Kassiopeia
3,365,000NOK 7.4m0%no data
0.94%
KLP Kapitalforvaltning AS
3,061,555NOK 6.7m0%no data
0.92%
Borgano AS
3,000,000NOK 6.6m0%no data
0.87%
Danske Invest Asset Management AS
2,825,498NOK 6.2m0%0.42%
0.83%
Swedbank Asset Management AS SMB
2,719,181NOK 5.9m0%0.58%
0.82%
Danske Capital AB
2,682,839NOK 5.9m0%0.09%
0.78%
Alden AS
2,550,000NOK 5.6m0%no data
0.73%
Datum Finans As
2,395,500NOK 5.2m0%no data
0.69%
Northern Trust Global Investments
2,255,034NOK 4.9m0%no data
0.66%
Caaby AS
2,155,295NOK 4.7m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/19 03:47
End of Day Share Price 2025/11/19 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nykode Therapeutics AS is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Viktor SundbergABG Sundal Collier Sponsored
Geir HolomDNB Carnegie
Lucy CodringtonJefferies LLC